| Michael R Hejtmanek, MD | |
|
2980 Squalicum Pkwy, Suite 304, Bellingham, WA 98225-1880 | |
| (360) 647-3377 | |
| (360) 752-3214 |
| Full Name | Michael R Hejtmanek |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 2980 Squalicum Pkwy, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386788115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD00048259 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Sound Anesthesia Associates Pllc | 6204726383 | 3 |
News Archive
The manager of a music store has been charged with the exploitation of the elderly, after allowing a woman with Alzheimer's disease to buy 11 organs from him over 18 months and that included four on one single day.
Royal Philips today announced that it will unveil its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which will be held in Barcelona (Spain) from September 10 until 14.
The Medica Foundation today announced $1 million in grants to five Minnesota organizations. The grant amounts range from $100,000 to $300,000 each and are designed to provide funding to the recipients over a three-year period.
Raptor Pharmaceutical Corp. announced that it has enrolled the first patient in a pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 4 days ago
| Entity Name | South Sound Anesthesia Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427108398 PECOS PAC ID: 6204726383 Enrollment ID: O20040319001401 |
News Archive
The manager of a music store has been charged with the exploitation of the elderly, after allowing a woman with Alzheimer's disease to buy 11 organs from him over 18 months and that included four on one single day.
Royal Philips today announced that it will unveil its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which will be held in Barcelona (Spain) from September 10 until 14.
The Medica Foundation today announced $1 million in grants to five Minnesota organizations. The grant amounts range from $100,000 to $300,000 each and are designed to provide funding to the recipients over a three-year period.
Raptor Pharmaceutical Corp. announced that it has enrolled the first patient in a pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael R Hejtmanek, MD 2980 Squalicum Pkwy, Suite 304, Bellingham, WA 98225-1880 Ph: (360) 647-3377 | Michael R Hejtmanek, MD 2980 Squalicum Pkwy, Suite 304, Bellingham, WA 98225-1880 Ph: (360) 647-3377 |
News Archive
The manager of a music store has been charged with the exploitation of the elderly, after allowing a woman with Alzheimer's disease to buy 11 organs from him over 18 months and that included four on one single day.
Royal Philips today announced that it will unveil its latest innovation in interventional oncology at the 2016 Cardiovascular and Interventional Radiological Society of Europe annual meeting (CIRSE 2016), which will be held in Barcelona (Spain) from September 10 until 14.
The Medica Foundation today announced $1 million in grants to five Minnesota organizations. The grant amounts range from $100,000 to $300,000 each and are designed to provide funding to the recipients over a three-year period.
Raptor Pharmaceutical Corp. announced that it has enrolled the first patient in a pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 4 days ago
John Erik Schroeter, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2980 Squalicum Pkwy, Suite 105, Bellingham, WA 98225 Phone: 360-647-3377 Fax: 360-752-3214 | |
Robert Kahn, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2901 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-734-5400 | |
Arjun Chenna Reddy, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 909 Squalicum Way Ste 102, Bellingham, WA 98225 Phone: 606-473-3773 | |
Dr. Gregory Carl Sund, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 2980 Squalicum Pkwy, Suite 304, Bellingham, WA 98225 Phone: 360-647-3377 Fax: 360-752-3214 | |
Dr. John Edwin Morrison, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 909 Squalicum Way Ste 102, Bellingham, WA 98225 Phone: 360-647-3377 | |
Dr. Nishan Bingham, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 909 Squalicum Way Ste 102, Bellingham, WA 98225 Phone: 360-647-3377 Fax: 360-752-3214 | |
Robert Todd Campbell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2980 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-647-3377 Fax: 360-752-3214 |